Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases

A. Trachalaki (Herakleion, Greece), E. Tsitoura (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), E. Bibaki (Herakleion, Greece), G. Papastratigakis (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), N. Tzanakis (Herakleion, Greece), K. Antoniou (Herakleion, Greece)

Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Session: Back to basics and translational research in idiopathic interstitial pneumonias
Session type: Thematic Poster
Number: 4813
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Trachalaki (Herakleion, Greece), E. Tsitoura (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), E. Bibaki (Herakleion, Greece), G. Papastratigakis (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), N. Tzanakis (Herakleion, Greece), K. Antoniou (Herakleion, Greece). Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases. 4813

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases
Source: Eur Respir J, 55 (2) 1900460; 10.1183/13993003.00460-2019
Year: 2020



Contribution of myeloperoxidase to inflammatory processes in lung epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 853s
Year: 2006

LSC - 2019 - Inflammasomes’ activation in alveolar macrophages and peripheral blood mononuclear cells in fibrotic Interstitial Lung Diseases
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells
Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease
Year: 2004


Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006



Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006

Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 543s
Year: 2005

N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007


Compartimentalized in-vitro TNF-α production of alveolar macrophages and peripheral mononuclear cells after severe trauma
Source: Eur Respir J 2001; 18: Suppl. 33, 317s
Year: 2001

Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006



Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005

Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013


Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Comparison of peripheral lung and airway tissue inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010


Inflammasome activation in airway macrophages and the lung microbiome in IPF
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Regulation of pulmonary inflammation and its consequences by collectins and apoptotic cells
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004

A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages
Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019
Year: 2020